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Abstract: Monodispersed spherical Ag-doped bioactive glass nanoparticles (Ag-BGNs) were
synthesized by a modified Stöber method combined with surface modification. The surface
modification was carried out at 25, 60, and 80 ˝C, respectively, to investigate the influence of
processing temperature on particle properties. Energy-dispersive X-ray spectroscopy (EDS) results
indicated that higher temperatures facilitate the incorporation of Ag. Hydroxyapatite (HA) formation
on Ag-BGNs was detected upon immersion of the particles in simulated body fluid for 7 days, which
indicated that Ag-BGNs maintained high bioactivity after surface modification. The conducted
antibacterial assay confirmed that Ag-BGNs had an antibacterial effect on E. coli. The above results
thereby suggest that surface modification is an effective way to incorporate Ag into BGNs and that the
modified BGNs can remain monodispersed as well as exhibit bioactivity and antibacterial capability
for biomedical applications.
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1. Introduction
Bioactive glasses (BGs) are promising biomaterials for bone regeneration due to their
osteoconductivity and osteoinductivity. The first developed BG, well-known as 45S5 Bioglass®, is
based on the SiO2-P2O5-CaO-Na2O composition [1]. Further developments in BG compositions, such
as the introduction of therapeutic ions (e.g., Ag+, Cu2+ or Sr2+), can bring new advantages and novel
applications to conventional BGs, including, soft tissue regeneration, wound healing, and antibacterial
applications [2,3].
Bioactive glass nanoparticles (BGNs) have advantages over bulk BGs for biomedical applications
due to their larger surface area, higher bioactivity, as well as controllable and homogenous size [4].
BGNs are usually synthesized by sol-gel-based methods [4]. However, preparation of monodispersed
BGNs is still challenging, as the addition of salt precursors may interfere with the nucleation and
growth of primary silica particles, consequently leading to irregular and aggregated particles [5].
To synthesize monodispersed BGNs, the type and amount salt precursors (e.g., calcium salts) must be
carefully controlled [6,7].
Infection is one of the challenges during implantation, which can cause implant failure or tissue
necrosis [8,9]. Incorporating antiseptic ions into the composition of materials is a potential alternative
to treat or prevent infections, otherwise carried out by the administration of antibiotics. It is well
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known that silver (Ag) has broad-spectrum antibacterial activity; therefore, Ag+ ion release is a popular
approach investigated in the context of antibacterial biomaterials [10–12].
Silver-doped BGNs (Ag-BGNs) can exhibit the bioactive characteristics of BGNs as well as
showing antibacterial capacity and are therefore investigated for various applications. However, most
Ag-BGNs introduced in previous reports appeared to be highly aggregated [13–15], which may limit
their application as building blocks for development of nanocomposites. Surface modification is
a convenient approach to introduce Ag ions into glasses [16]. Monodispersed Ag-doped silica particles
have been synthesized by such surface modification methods using silver nitrates, and they have
shown considerable antibacterial effects [17].
Based on the know-how available in the literature, we hypothesized that BGNs could adsorb
Ag+ ions by a surface modification routine and still be monodispersed. Sol-gel-derived BGNs
usually have high concentration of silanol groups and negative net charges at the surface [5], which
may be beneficial to the adsorption of positively charged Ag+ ions. The aim of this research was
to prepare monodispersed Ag-BGNs exhibiting bioactivity and antibacterial properties by surface
modification at relatively low temperatures. Monodispersed BGNs were synthesized by a modified
Stöber method, and the following surface modification process involved the use of a silver nitrate
aqueous solution. The morphology of BGNs before and after surface modification was observed using
field emission scanning electron microscopy (FE-SEM), and the composition of the BGNs was analyzed
with energy-dispersive X-ray spectroscopy (EDS). The possible presence of crystalline phases was
investigated by X-ray diffraction (XRD) and Fourier-transform infrared spectroscopy (FTIR). Moreover,
the in vitro mineralization and the antibacterial activity of Ag-BGNs were evaluated.
2. Results and Discussion
The as-synthesized BGNs were monodispersed and showed a spherical shape (Figure 1a), which
is the typical morphology of particles synthesized by the Stöber method [6]. After surface modification
with Ag nitrates, all the particles still maintained the spherical shape (Figure 1). Additionally, the sizes
of BGNs and all Ag-BGNs were comparable (Table 1). The particles modified at different temperatures
showed a similar spherical shape, surface morphology and particle size, indicating that the surface
modification did not affect the key characteristics of particles.
Table 1. Composition determined by energy-dispersive X-ray spectroscopy (EDS) and particle size of
non-modified and Ag-modified bioactive glass nanoparticles (BGNs).
Name Composition (mol%) Particles Size (nm)
BGN 96.60SiO2-3.40CaO 370 ˘ 35
Ag-25 95.61SiO2-4.26CaO-0.12Ag2O 365 ˘ 23
Ag-60 95.46SiO2-4.35CaO-0.19Ag2O 373 ˘ 25
Ag-80 95.69SiO2-4.07CaO-0.24Ag2O 367 ˘ 24
Table 1 lists the compositions and particle size of the obtained BGNs. As can be seen, Ag was
incorporated in BGNs successfully. Different possible mechanisms can be considered to describe the
incorporation of Ag in BGNs. Firstly, positively charged Ag+ ions can be adsorbed on negatively
charged BGNs through electrostatic interactions. In addition, Ag+ ions from the aqueous solution
could be incorporated by an ion exchange process with calcium ions in BGNs [18,19]. Moreover, Ag+
ions may diffuse into the BGNs, as particles synthesized by the Stöber method contain nanopores
on the surface [20]. Notably, the content of Ag in BGNs increased with increasing temperature.
This phenomenon is likely due to the higher diffusion mobility of Ag+ ions at higher temperatures. It is
important to notice that the final composition of BGNs was different from the nominal composition.
This result could be attributed to the high solubility of calcium nitrate during the period of reaction
and the further loss of calcium caused by washing, which is consistent with the results from previous
studies [6,21].
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Figure 1. Scanning electron microscopy (SEM) images of samples before and after soaking in SBF for 
7 days. (A) BGNs; (B) Ag-25; (C) Ag-60; (D) Ag-80; (E) BGNs 7d; (F) Ag-25 7d; (G) Ag-60 7d;  
(H) Ag-80 7d. Inserted are the corresponding energy-dispersive X-ray spectroscopy (EDS) results. 
A broad shoulder starting at 2θ = ~20° can be seen in the XRD patterns (Figure 2a) of all 
samples, which is a typical characteristic peak for amorphous silicate materials [6]. Another broad 
band can be seen at around 32°, which could be attributed to amorphous calcium silicate species [22]. 
No significant differences could be found in the XRD patterns of Ag-BGNs. These results suggest 
that particles did not change their amorphous feature, and no silver-related crystalline phase was 
developed after surface modification. As can be seen in the FTIR spectra (Figure 2b), BGNs and 
Figure 1. Scanning electron microscopy (SEM) images of samples before and after soaking in SBF for
7 days. (A) BGNs; (B) Ag-25; (C) Ag-60; (D) Ag-80; (E) BGNs 7d; (F) Ag-25 7d; (G) Ag-60 7d; (H) Ag-80
7d. Inserted are the corresponding energy-dispersive X-ray spectroscopy (EDS) results.
A broad shoulder starting t 2θ = ~20˝ c n be seen in the XRD patterns (Figure 2a) of all samples,
which is a typical characteristic peak for amorphous silica e materials [6]. Another broad band can be
seen at around 32˝, which could be attributed to amorphous calcium silicate peci [22]. No ignificant
differences could be found in the XRD patterns of Ag-BGNs. These results suggest that particles did
not change their amorphous feature, and no silver-related crystalline phase was developed after
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surface modification. As can be seen in the FTIR spectra (Figure 2b), BGNs and Ag-BGNs show
the characteristic bands of silicate glasses. A wide band located in the range 1000–1200 cm´1 could
be attributed to Si–O–Si symmetric stretching vibration. Bands at 806 and 474 cm´1 are ascribed
to symmetric stretching and rocking mode of Si–O–Si, respectively [15,23,24]. All the above results
indicate that the surface modification did not influence the structure; thus, it was expected that
Ag-BGNs could maintain the properties of BGNs, e.g., bioactivity.
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washing and centrifugation, some individual BGNs without well-exposure to SBF were detached 
from BGN-apatite clusters and were then placed on top of the crystals). Similar SEM images of BGNs 
after soaking in SBF can be found in previous reports [25,26]. In addition, P could be detected on 
Ag-BGNs after soaking in SBF (Figure 1). The Ca/P ratio of the crystals formed on Ag-BGNs was 
near 1.64, which is close to the Ca/P ratio of stoichiometric HA. In addition, two new bands at 
around 563 and 604 cm−1 can be seen in the FTIR spectra (Figure 2b) of Ag-BGNs soaked in SBF for  
7 days. These two bands are characteristic bands of HA, which could be attributed to P–O 
asymmetric bending in apatite crystals [24]. Based on the SEM, FTIR, and EDS results, it can be 
concluded that Ag-BGNs were bioactive in the sense that HA crystals could form on them upon 
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Ag-25 was selected for antibacterial tests as it had the lowest content of Ag (Table 1). Higher Ag 
contents should lead to stronger antibacterial activity, but they present possible cytotoxic effects. The 
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concentration of Ag in Ag-25, and the released Ag+ ions could not reach the minimum inhibitory 
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Figure 2. (a) X-ray diffraction (XRD) patterns of BGNs and surface modified Ag-BGNs;
(b) Fourier-transform infrared spectroscopy (FTIR) spectra of Ag-BGNs before and after soak in
SBF for 7 days.
Crystals exhibiting the typical morphology of HA [24] could be s e both on BGNs and Ag-BGNs
after soaking in SBF for 7 days (Figure 1E–H). It should be noted that some BGNs were located inside
the crystals while some BGNs were present on the top of the crystals. During immersion in SBF,
HA crystals firstly formed around BGNs, and then the crystals continued forming and growing all
throughout the immersion period. However, considering the small size of the BGNs, HA crystals did
not form a typical cauliflower-like morphology on the surface of BGNs. The large apatite crystals could
only cluster themselves and grow beyond nanoparticles. In this study, BGNs inside the crystals should
therefore induce HA form ti n, while the particles on the top of the apatite crystals are believed to
be caused by the processes of sample pr par tion for SEM (after washing and centrifugation, ome
individual BGNs without well-exposure to SBF were detached from BGN-apatite clusters and were
then placed on top of the crystals). Similar SEM images of BGNs after soaking in SBF can be found in
previous reports [25,26]. In addition, P could be detected on Ag-BGNs after soaking in SBF (Figure 1).
The Ca/P ratio of the crystals formed on Ag-BGNs was near 1.64, which is close to the Ca/P ratio of
stoichiometric HA. In addition, two new bands at around 563 and 604 cm´1 can be seen in the FTIR
spectra (Figure 2b) of Ag-BGNs soaked in SBF for 7 days. These two bands are characteristic bands of
HA, which could be attributed to P–O asymmetric bending in apatite crystals [24]. Based on the SEM,
FTIR, and EDS results, it can be concluded hat Ag-BGNs were bioac ive in the sense that HA crystals
could form on them upon soaking in SBF for 7 days.
Ag-25 was selected for antibacterial tests as it had the lowest content f Ag (T ble 1). Higher
Ag contents should lead to stronger antibacterial activity, but they present possible cytotoxic effects.
The results of antibacterial tests are shown in Figure 3. As expected, BGNs did not show antibacterial
effects on both E. coli and B. subtilis As a comparison, Ag-25 exhibited antibacterial effects on E. coli,
while no effects towards B. subtilis could be observed. This result could be due to the low concentration
of Ag in Ag-25, and the released Ag+ ions could not reach the minimum inhibitory concentration of
B. subtilis. Previous research has shown that Gram-negative E. coli was more susceptible to silver than
Gram-positive Staphylococcus aureus due to the difference in cell walls structure [27,28]. Considering
the antibacterial effects of Ag-25, it can be concluded that all modified Ag-BGNs produced in this
study should possess antibacterial capability.
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As silver nanoparticles could induce toxicity towards cells [29], Ag-doped BGs could also cause
cytotoxic effects. It has been reported that the cytotoxicity of Ag-doped BGs depended on the used
concentration of materials and on the culture time [30]. To the best of our knowledge, comprehensive
reports on the cytotoxicity of Ag-containing BGNs have not been published so far. The cytotoxicity of
Ag-BGNs should also depend on the used concentration and culture time. The detailed biocompatibility
assessment and the biological properties of Ag-BGNs will be investigated in further studies.
3. Materials and Methods
3.1. Synthesis of BGNs
BGNs were synthesized by a modified Stöber method. Briefly, one solution containing 25 mL
ethanol (VWR, Darmstadt, Germany) and 3 mL tetraethyl orthosilicate (Sigma-Aldrich, Munich,
Germany) was added into another solution containing distilled water (12.4 mL), ethanol (8.12 mL), and
ammonia (4.5 mL, 28%, VWR) under continuous stirring. After 30 min of reaction, 1.35 g calcium nitrate
tetrahydrate (CaNO3¨ 4H2O; Sigma-Aldrich) was added into the suspension and stirred for further
1.5 h before being centrifuged and washed twice with water and once with ethanol. The collected
deposits were dried at 60 ˝C for 4 h, followed by calcination at 700 ˝C for 2 h with a heating rate of
2 ˝C/min.
3.2. Surface Modification
The as-prepared BGNs (0.5 g) were soaked in 20 mL of a 0.5-M silver nitrate (AgNO3;
Sigma-Aldrich) aqueous solution at 25, 60, and 80 ˝C for 6 h, respectively. The suspension was
then centrifuged and washed twice with distilled water. The obtained wet powders were dried at
60 ˝C for 3 h and then sintered at 560 ˝C for 1 h with a rate of 2 ˝C/min to stabilize the structure and
to remove residual nitrates. The obtained samples were named Ag-25, Ag-60, and Ag-80 according to
the temperatures used (25, 60, and 80 ˝C).
3.3. Characterization
The morphology of Ag-BGNs was observed by FE-SEM (Auriga, Carl-Zeiss, Jena, Germany).
The particle size was determined from SEM images, measuring around 100 particles by means of
ImageJ software (National Institutes of Health, Bethesda, MD, USA). The composition of particles
was investigated by EDS. FTIR (Nicolet 6700, Thermo Scientific, Schwerte, Germany) was performed
using the KBr (Merck, Darmstadt, Germany) pellet method. The weight ratio of sample to KBr was
set at 1:100. For the analysis, 32 scans at a resolution of 4 cm´1 were performed in the wavenumber
range 2000–400 cm´1. A Bruker D8 Discover diffractometer (Bruker, Karlsruhe, Germany) with Cu Kα
radiation at 40 kV and 30 mA was used to record XRD patterns in a 2θ range of 10˝–80˝ with a step
size of 0.014˝/step.
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3.4. In Vitro Mineralization
The in vitro mineralization of Ag-BGNs was investigated by soaking samples in SBF [31] at a ratio
of 1 mg/mL for 7 days. The samples were kept in an incubator at 37 ˝C and 90 rpm for up to 7 days.
At pre-determined time points, the suspension was centrifuged, washed twice with distilled water,
and then dried at 60 ˝C for 3 h. Apatite formation on the samples was evaluated using FTIR, FE-SEM,
and EDS.
3.5. Antibacterial Assessment
Ag-25 was selected for antibacterial tests given its lowest amount of Ag. The test was carried
out as described in the literature [32]. Briefly, Ag-25 was immersed in phosphate buffered saline
for 24 h at a concentration of 1 mg/mL at room temperature. PBS was used as a blank control and
BGNs as a negative control. Before assessment, Gram-positive B. subtilis and Gram-negative E. coli
were cultured in the nutrient for 24 h at 37 ˝C. Wells of a sterilized 96-well plate were inoculated with
50 µL of the particle suspension and 50 µL of bacterial suspension for 16 h. Tests were conducted
in quadruplicate. The optical density of 600 nm (OD 600) was measured spectrophotometrically
with a microplate reader (Biotek, Bad Friedrichshall, Germany). Since the optical density might have
interfered with the samples, the OD value of the samples before culture was removed from the final
results as the background.
4. Conclusions
Monodispersed, bioactive Ag-BGNs were successfully synthesized by a modified Stöber method
followed by surface modification at relatively low temperatures (25 to 80 ˝C) to incorporate Ag.
The particle size was around 370 nm. With the rise of temperature, the incorporated Ag content
increased. The modification had no obvious influence on the morphology, size, and structure of
particles. HA formed on Ag-BGNs upon soaking in SBF for 7 days. Antibacterial tests showed that the
presence of Ag-BGNs (Ag-25) could inhibit the growth of E. coli. The results have demonstrated a facile
surface modification method to incorporate Ag into bioactive glass nanoparticles. The modified BGNs
remain monodisperse, are bioactive, and acquire antibacterial capability. Ag-BGNs are thus promising
materials for biomedical applications.
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